Brookstone Capital Management Ionis Pharmaceuticals Inc Transaction History

Brookstone Capital Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 13, 2022	BUY	$36.54 - $48.66 $463,838 - $617,690	12,694 Added 50.09%	38,035 $1.75 Million
Q2 2022 Jul 11, 2022	BUY	$31.71 - $43.0 $94,178 - $127,710	2,970 Added 13.28%	25,341 $941,000
Q1 2022 Apr 12, 2022	BUY	$29.88 - $37.04 $251,709 - $312,024	8,424 Added 60.4%	22,371 $886,000
Q4 2021 Jan 11, 2022	BUY	$25.61 - $35.1 $65,305 - $89,505	2,550 Added 22.37%	13,947 $424,000
Q3 2021 Nov 03, 2021	BUY	$33.54 - $40.55 $382,255 - $462,148	11,397 New	11,397 $382,000

403

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $4.75B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Brookstone Capital Management, based on Form 13F filings with the SEC.

Stay updated on Brookstone Capital Management with notifications on news.